These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34216297)

  • 21. Myasthenia gravis, dermatomyositis, and polymyositis: immunopathological diseases.
    Penn AS
    Adv Neurol; 1977; 17():41-61. PubMed ID: 302085
    [No Abstract]   [Full Text] [Related]  

  • 22. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
    Edmonston DL; South AM; Sparks MA; Cohen JB
    Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
    Saba L; Gerosa C; Fanni D; Marongiu F; La Nasa G; Caocci G; Barcellona D; Balestrieri A; Coghe F; Orru G; Coni P; Piras M; Ledda F; Suri JS; Ronchi A; D'Andrea F; Cau R; Castagnola M; Faa G
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12609-12622. PubMed ID: 33336781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G; Clapasson A; Cozzani E; Sanna L; Pesce G; Bagnasco M; Burlando M; Parodi A
    Arch Dermatol Res; 2017 Mar; 309(2):87-95. PubMed ID: 27928683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Four dermatomyositis-specific autoantibodies-anti-TIF1γ, anti-NXP2, anti-SAE and anti-MDA5-in adult and juvenile patients with idiopathic inflammatory myopathies in a Hungarian cohort.
    Bodoki L; Nagy-Vincze M; Griger Z; Betteridge Z; Szöllősi L; Dankó K
    Autoimmun Rev; 2014 Dec; 13(12):1211-9. PubMed ID: 25182203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review.
    Stewart JA; Price T; Moser S; Mullikin D; Bryan A
    Pediatr Rheumatol Online J; 2022 Feb; 20(1):16. PubMed ID: 35193600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How kids' immune systems can evade COVID.
    Nogrady B
    Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
    [No Abstract]   [Full Text] [Related]  

  • 29. Insights into pathogenesis and clinical implications in myositis-associated interstitial lung diseases.
    Yanagihara T; Inoue Y
    Curr Opin Pulm Med; 2020 Sep; 26(5):507-517. PubMed ID: 32657836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benign acute viral myositis in African migrants: A clinical, serological, and pathological study.
    Pancheri E; Lanzafame M; Zamò A; Angheben A; Sartoris S; Zorzi A; Boaretti M; Signoretto C; Guglielmi V; Ferrari S; Tonin P; Vattemi G
    Muscle Nerve; 2019 Nov; 60(5):586-590. PubMed ID: 31443116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complement in autoimmune inflammatory myopathies, the role of myositis-associated antibodies, COVID-19 associations, and muscle amyloid deposits.
    Dalakas MC
    Expert Rev Clin Immunol; 2022 Apr; 18(4):413-423. PubMed ID: 35323101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myositis due to COVID-19.
    Uslu S
    Postgrad Med J; 2021 Jun; 97(1148):399. PubMed ID: 33589489
    [No Abstract]   [Full Text] [Related]  

  • 33. Myositis-specific autoantibodies in Japanese patients with juvenile idiopathic inflammatory myopathies.
    Ueki M; Kobayashi I; Takezaki S; Tozawa Y; Okura Y; Yamada M; Kuwana M; Ariga T
    Mod Rheumatol; 2019 Mar; 29(2):351-356. PubMed ID: 29532710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Idiopathic inflammatory myopathies].
    Vencovský J
    Vnitr Lek; 2018; 64(2):155-163. PubMed ID: 29595280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dermatomyositis associated with anti-MDA5 autoantibody].
    Collado MV; Gargiulo MLÁ; Gómez R; Gómez G; Pérez N; Suarez L; Taratuto AL; Aruj P
    Medicina (B Aires); 2018; 78(5):360-363. PubMed ID: 30285929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies in polymyositis and dermatomyositis.
    Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
    Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific Autoantibodies.
    Wolstencroft PW; Fiorentino DF
    Curr Rheumatol Rep; 2018 Apr; 20(5):28. PubMed ID: 29637414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients.
    Garibaldi M; Fionda L; Vanoli F; Leonardi L; Loreti S; Bucci E; Di Pasquale A; Morino S; Vizzaccaro E; Merlonghi G; Ceccanti M; Lucchini M; Mirabella M; Andreetta F; Pennisi EM; Petrucci A; Salvetti M; Antonini G
    Autoimmun Rev; 2020 Apr; 19(4):102498. PubMed ID: 32062029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical spectrum of dermatomyositis and the new autoantibodies - with regard to two clinical cases with distinct associations.
    Calvão da Silva JCM; Santiago L; Brites MM; Gonçalo M
    Australas J Dermatol; 2020 May; 61(2):e241-e243. PubMed ID: 31881093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.